A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test

Cedar Associates LLC1 site in 1 country19 target enrollmentMay 2012

ConditionsNeoplasm Metastasis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Neoplasm Metastasis
Sponsor: Cedar Associates LLC
Enrollment: 19
Locations: 1
Primary Endpoint: Survival
Status: Terminated
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Registry

clinicaltrials.gov

Start Date

May 2012

End Date

February 2013

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Cedar Associates LLC

Responsible Party

Principal Investigator

John Hornberger, MD MS

CEO, President

Cedar Associates LLC

Eligibility Criteria

Inclusion Criteria

•their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013
•the patient is ≥ 18 years of age
•the patient has given informed consent (online or verbal)
•the patient is able to understand English.